EU Guideline On Investigational ATMPs Delayed Until Q3 2019
Executive Summary
Several factors have contributed towards a delay in the European Medicines Agency's much awaited guideline on investigational advanced therapy medicinal products, which was initially due to be finalized in the second quarter of 2017.